We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Digital Transcranial Doppler Device

By HospiMedica staff writers
Posted on 04 May 2001
Novel technology that can detect Stachybotrys chartarum, commonly known as black mold, and more than 50 other problematic fungi has been developed by researchers at the Office of Research and Development at the U.S. More...
Environmental Protection Agency (EPA). The polymerase chain reaction (PCR)-based system can identify and quantify fungal species in a matter of hours, versus days or weeks by other methods.

Stachybotrys chartarum typically grows in buildings affected by water damage and has been found in homes, hospitals, schools, and office buildings. Exposure to fungi has been identified as a possible cause of many health problems, including asthma, sinusitis, infections, and pulmonary hemosiderosis. Fungi are believed to play a major role in cases of building-related illnesses.

The U.S. Environmental Technology Commercialization Center (ETC2, Cleveland, OH, USA) is introducing the technology by licensing it on a non-exclusive basis to laboratories, indoor air quality specialists, or other environmental specialists. Up to 96 analyses can be run simultaneously by lab technicians, says ETC2, reducing the labor required to analyze samples while increasing the accuracy and validity of the analysis.

The first license was recently granted to Aerotech Laboratories (Phoenix, AZ, USA) for indoor air quality testing. The company also plans to use the technology to develop its BioGard microbial surveillance system for use in healthcare facilities to monitor for Mycobacterium tuberculosis, Aspergillus, and Legionella.




Related Links:
ETC2

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.